Jeroen De Roos

Title: Jeroen De Roos: Innovator in Cancer Treatment

Introduction

Jeroen De Roos is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of two patents to his name, De Roos is dedicated to advancing medical science and improving patient outcomes.

Latest Patents

One of Jeroen De Roos's latest patents focuses on prognostic biomarkers for TTK inhibitor chemotherapy. This method involves identifying tumors that are susceptible to treatment with a TTK inhibitor. The process includes providing a sample of a tumor and determining the presence of a mutated CTNNB1 gene in the sample. The mutation is specifically located in exon 3 of the CTNNB1 gene, and its presence indicates that the tumor is likely to respond to TTK inhibitor treatment. Alternatively, the method can involve determining the presence of a mutated CTNNB1 protein or assessing altered expression of a CTNNB1 regulated gene, both of which also indicate susceptibility to treatment.

Career Highlights

Jeroen De Roos is associated with the Netherlands Translational Research Center B.V., where he continues to work on groundbreaking research in cancer therapies. His dedication to innovation in this field has positioned him as a key figure in the development of new treatment methodologies.

Collaborations

Throughout his career, De Roos has collaborated with esteemed colleagues, including Joost Cornelis Marinus Uitdehaag and Adrianus Petrus Antonius De Man. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer treatments.

Conclusion

Jeroen De Roos is a prominent inventor whose work in cancer treatment is paving the way for new therapeutic approaches. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes for patients.